ALNY vs ANGO · P/E 76, rev $3.71B vs rev $292.5M
Alnylam Pharmaceuticals Inc (ALNY) versus AngioDynamics Inc (ANGO) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
AngioDynamics Inc (ANGO) is a medical instruments & supplies company listed on US.
Latest reported ALNY revenue for 2025-12-31 was $3.71B. Net income was $313.7M. Revenue was up 65.2% from 2024-12-31 to 2025-12-31. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
Latest reported ANGO revenue for 2025-05-31 was $292.5M. Net income was -$34.0M. Revenue was down 3.8% from 2024-05-31 to 2025-05-31. ANGO currently screens at market cap $378.5M.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. ANGO currently screens at market cap $378.5M.
Not investment advice. Open the ALNY and ANGO stock pages for the full models.
Not investment advice.